CAMBIAR INVESTORS LLC

Position in NVS — Novartis AG

CIK 823621 Denver, CO

Position in NVS

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$203,892

-$13,929 QoQ

Shares Held

1,301

-8.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,312

of 1,603 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 81% Shared 0% None 19%

Healthcare · as of Jun 30, 2026

CAMBIAR INVESTORS LLC holds $97,555,817 across 4 Drug Manufacturers - General names. NVS ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	1,017,517	$58,629,329
2	AZN	Astrazeneca PLC	129,899	$24,631,448
3	NVO	Novo Nordisk A S	293,933	$14,091,148
4	NVS	Novartis AG This page	1,301	$203,892

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$203,892	1,301	-8.8%	Shares	Sole	2026-07-31
2026-03-31	$217,821	1,426	-32.5%	Shares	Sole	2026-05-12
2025-12-31	$291,457	2,114	0.0%	Shares	Sole	2026-01-23
2025-09-30	$271,099	2,114	-8.2%	Shares	Sole	2025-11-03
2025-06-30	$278,686	2,303	-44.0%	Shares	Sole	2025-08-05
2025-03-31	$458,517	4,113	-96.6%	Shares	Sole	2025-05-13
2024-12-31	$11,869,387	121,975	-2.9%	Shares	Sole	2025-01-29
2024-09-30	$14,447,547	125,609	-42.0%	Shares	Sole	2024-10-28
2024-06-30	$23,065,197	216,656	+52.9%	Shares	Sole	2024-07-26
2024-03-31	$13,708,382	141,718	-9.2%	Shares	Sole	2024-05-02
2023-12-31	$15,763,840	156,124	-34.6%	Shares	Sole	2024-01-25
2023-09-30	$24,310,009	238,661	-6.8%	Shares	Sole	2023-10-30
2023-06-30	$25,828,217	255,953	-16.8%	Shares	Sole	2023-07-31
2023-03-31	$28,308,952	307,706	+1.2%	Shares	Sole	2023-05-08
2022-12-31	$27,597,659	304,207	-7.9%	Shares	Sole	2023-02-02
2022-09-30	$25,102,150	330,248	—	Shares	Sole	2022-10-28
No filing history on record for this holder in this stock.